Assure Holdings Inkomsten in het verleden
Verleden criteriumcontroles 0/6
Assure Holdings's earnings have been declining at an average annual rate of -38.3%, while the Healthcare industry saw earnings growing at 5.4% annually. Revenues have been declining at an average rate of 31.7% per year.
Belangrijke informatie
-38.3%
Groei van de winst
0.04%
Groei van de winst per aandeel
Healthcare Groei van de industrie | 8.5% |
Inkomstengroei | -31.7% |
Rendement op eigen vermogen | n/a |
Nettomarge | 519.8% |
Laatste winstupdate | 30 Jun 2024 |
Recente prestatie-updates uit het verleden
Recent updates
Opbrengsten en kosten
Hoe Assure Holdings geld verdient en uitgeeft. Gebaseerd op laatst gerapporteerde winst, op LTM-basis.
Inkomsten en omzetgeschiedenis
Datum | Inkomsten | Inkomsten | G+A Uitgaven | R&D-uitgaven |
---|---|---|---|---|
30 Jun 24 | -4 | -22 | 12 | 0 |
31 Mar 24 | -4 | -23 | 14 | 0 |
31 Dec 23 | -4 | -21 | 14 | 0 |
30 Sep 23 | -1 | -26 | 14 | 0 |
30 Jun 23 | -1 | -24 | 14 | 0 |
31 Mar 23 | -5 | -24 | 14 | 0 |
31 Dec 22 | -1 | -23 | 15 | 0 |
30 Sep 22 | 10 | -10 | 16 | 0 |
30 Jun 22 | 18 | -6 | 16 | 0 |
31 Mar 22 | 29 | -4 | 17 | 0 |
31 Dec 21 | 29 | -3 | 16 | 0 |
30 Sep 21 | 25 | -3 | 15 | 0 |
30 Jun 21 | 21 | -4 | 14 | 0 |
31 Mar 21 | 4 | -16 | 12 | 0 |
31 Dec 20 | 4 | -15 | 11 | 0 |
30 Sep 20 | -7 | -21 | 10 | 0 |
30 Jun 20 | -3 | -17 | 10 | 0 |
31 Mar 20 | 16 | 1 | 10 | 0 |
31 Dec 19 | 18 | 3 | 10 | 0 |
30 Sep 19 | 19 | 4 | 9 | 0 |
30 Jun 19 | 18 | 4 | 8 | 0 |
31 Mar 19 | 15 | 3 | 7 | 0 |
31 Dec 18 | 15 | 4 | 6 | 0 |
30 Sep 18 | 23 | -1 | 20 | 0 |
30 Jun 18 | 20 | -2 | 21 | 0 |
31 Mar 18 | 18 | -5 | 21 | 0 |
31 Dec 17 | 16 | -6 | 20 | 0 |
30 Sep 17 | 15 | 6 | 4 | 0 |
30 Jun 17 | 13 | 5 | 3 | 0 |
31 Mar 17 | 9 | 6 | 2 | 0 |
31 Dec 16 | 6 | 4 | 1 | 0 |
Kwaliteitswinsten: IONM is currently unprofitable.
Groeiende winstmarge: IONM is currently unprofitable.
Analyse vrije kasstroom versus winst
Analyse van de winstgroei in het verleden
Winsttrend: IONM is unprofitable, and losses have increased over the past 5 years at a rate of 38.3% per year.
Versnelling van de groei: Unable to compare IONM's earnings growth over the past year to its 5-year average as it is currently unprofitable
Winst versus industrie: IONM is unprofitable, making it difficult to compare its past year earnings growth to the Healthcare industry (11.4%).
Rendement op eigen vermogen
Hoge ROE: IONM's liabilities exceed its assets, so it is difficult to calculate its Return on Equity.